← Leaderboards
Tim Greten
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMalignant NeoplasmsCellsImmuneBaseTumor GrowthImmune ResponseTumor EscapeLiverMyelogenousMalignant Neoplasm Of Gastrointestinal TractT-LymphocyteImmunotherapySuppressor-Effector T-LymphocytesMalignant Neoplasm Of PancreasClinical ProtocolsPrimary Carcinoma Of The Liver CellsGastrointestinal NeoplasmsUnited StatesInfectionCarcinomaCessation Of LifeMalignant Neoplasm Of LiverAffect
Grant awards (65)
Analysis of cancer-related immune suppressor mechanisms in mice$2,337,175
ZIA · FY2025 · CA · contact PI
Center for Cell-based Therapy - Cures$867,748
ZIA · FY2025 · CA · contact PI
Clinical protocols for the treatment of gastrointestinal cancer$623,247
ZIA · FY2025 · CA · contact PI
Immune suppressor mechanisms in patients with GI cancer$155,811
ZIA · FY2025 · CA · contact PI
Analysis of cancer-related immune suppressor mechanisms in mice$2,219,937
ZIA · FY2024 · CA · contact PI
Center for Cell-based Therapy - Cures$697,518
ZIA · FY2024 · CA · contact PI
Clinical protocols for the treatment of gastrointestinal cancer$591,982
ZIA · FY2024 · CA · contact PI
Immune suppressor mechanisms in patients with GI cancer$147,995
ZIA · FY2024 · CA · contact PI
Analysis of cancer-related immune suppressor mechanisms in mice$1,906,828
ZIA · FY2023 · CA · contact PI
Clinical protocols for the treatment of gastrointestinal cancer$508,487
ZIA · FY2023 · CA · contact PI
Center for Cell-based Therapy - Cures$208,597
ZIA · FY2023 · CA · contact PI
Immune suppressor mechanisms in patients with GI cancer$127,122
ZIA · FY2023 · CA · contact PI
Analysis of cancer-related immune suppressor mechanisms in mice$1,913,193
ZIA · FY2022 · CA · contact PI
Clinical protocols for the treatment of gastrointestinal cancer$510,185
ZIA · FY2022 · CA · contact PI
Center for Cell-based Therapy - Cures$174,423
ZIA · FY2022 · CA · contact PI
Immune suppressor mechanisms in patients with GI cancer$127,546
ZIA · FY2022 · CA · contact PI
Center for Cell-based Therapy - Cures$2,493,170
ZIA · FY2021 · CA · contact PI
Analysis of cancer-related immune suppressor mechanisms in mice$1,701,391
ZIA · FY2021 · CA · contact PI
Clinical protocols for the treatment of gastrointestinal cancer$431,019
ZIA · FY2021 · CA · contact PI
Immune suppressor mechanisms in patients with GI cancer$113,427
ZIA · FY2021 · CA · contact PI
The effect of hydroxychloroquine treatment on immune checkpoint inhibitors$22,685
ZIA · FY2021 · CA · contact PI
Center for Cell-based Therapy - Cures$2,065,053
ZIA · FY2020 · CA · contact PI
Analysis of cancer-related immune suppressor mechanisms in mice$1,746,960
ZIA · FY2020 · CA · contact PI
Clinical protocols for the treatment of gastrointestinal cancer$349,391
ZIA · FY2020 · CA · contact PI
The effect of hydroxychloroquine treatment on immune checkpoint inhibitors$116,464
ZIA · FY2020 · CA · contact PI
Immune suppressor mechanisms in patients with GI cancer$116,464
ZIA · FY2020 · CA · contact PI
Analysis of cancer-related immune suppressor mechanisms in mice$1,692,953
ZIA · FY2019 · CA · contact PI
Clinical protocols for the treatment of gastrointestinal cancer$317,429
ZIA · FY2019 · CA · contact PI
Immune suppressor mechanisms in patients with GI cancer$105,810
ZIA · FY2019 · CA · contact PI
Analysis of cancer-related immune suppressor mechanisms in mice$1,443,413
ZIA · FY2018 · CA · contact PI
Clinical protocols for the treatment of gastrointestinal cancer$270,640
ZIA · FY2018 · CA · contact PI
Immune suppressor mechanisms in patients with GI cancer$90,214
ZIA · FY2018 · CA · contact PI
Analysis of cancer-related immune suppressor mechanisms in mice$1,147,070
ZIA · FY2017 · CA · contact PI
Clinical protocols for the treatment of gastrointestinal cancer$215,076
ZIA · FY2017 · CA · contact PI
Immune suppressor mechanisms in patients with GI cancer$71,692
ZIA · FY2017 · CA · contact PI
Analysis of cancer-related immune suppressor mechanisms in mice$1,064,344
ZIA · FY2016 · CA · contact PI
Clinical protocols for the treatment of gastrointestinal cancer$199,565
ZIA · FY2016 · CA · contact PI
Immune suppressor mechanisms in patients with GI cancer$66,522
ZIA · FY2016 · CA · contact PI
Analysis of cancer-related immune suppressor mechanisms in mice$896,773
ZIA · FY2015 · CA · contact PI
Clinical protocols for the treatment of gastrointestinal cancer$168,145
ZIA · FY2015 · CA · contact PI
Immune suppressor mechanisms in patients with GI cancer$56,048
ZIA · FY2015 · CA · contact PI
Immune suppressor mechanism in a murine model of hepatitis and liver cancer$528,324
ZIA · FY2014 · CA · contact PI
Analysis of cancer-related immune suppressor mechanisms in mice$462,283
ZIA · FY2014 · CA · contact PI
Clinical protocols for the treatment of gastrointestinal cancer$198,122
ZIA · FY2014 · CA · contact PI
Immune suppressor mechanisms in patients with GI cancer$132,081
ZIA · FY2014 · CA · contact PI
Immune suppressor mechanism in a murine model of hepatitis and liver cancer$432,799
ZIA · FY2013 · CA · contact PI
Analysis of cancer-related immune suppressor mechanisms in mice$370,970
ZIA · FY2013 · CA · contact PI
Clinical protocols for the treatment of gastrointestinal cancer$247,314
ZIA · FY2013 · CA · contact PI
Immune suppressor mechanisms in patients with GI cancer$123,656
ZIA · FY2013 · CA · contact PI
Analysis of tumor cell death on antigen-specific immune responses$61,829
ZIA · FY2013 · CA · contact PI
Immune suppressor mechanism in a murine model of hepatitis and liver cancer$392,983
ZIA · FY2012 · CA · contact PI
Analysis of tumor cell death on antigen-specific immune responses$224,562
ZIA · FY2012 · CA · contact PI
Analysis of myeloid derived suppressor cells in mice$224,562
ZIA · FY2012 · CA · contact PI
Immune suppressor mechanism analysis in patients with Hepatocellular Carcinoma$224,562
ZIA · FY2012 · CA · contact PI
Clinical protocols for the treatment of gastrointestinal cancer$56,140
ZIA · FY2012 · CA · contact PI
Analysis of immune suppressor mechanisms in patients with HCC$335,605
ZIA · FY2011 · CA · contact PI
Analysis of tumor cell death on antigen-specific immune responses$279,671
ZIA · FY2011 · CA · contact PI
Analysis of myeloid derived suppressor cells in mice$223,737
ZIA · FY2011 · CA · contact PI
Immune suppressor mechanism in a murine model of hepatitis and liver cancer$223,737
ZIA · FY2011 · CA · contact PI
Clinical protocols for the treatment of GI cancer$55,934
ZIA · FY2011 · CA · contact PI
Analysis of immune suppressor mechanisms in patients with HCC$206,642
ZIA · FY2010 · CA · contact PI
Analysis of tumor cell death on antigen-specific immune responses$172,201
ZIA · FY2010 · CA · contact PI
Analysis of myeloid derived suppressor cells in mice$137,761
ZIA · FY2010 · CA · contact PI
Immune suppressor mechanism in a murine model of hepatitis and liver cancer$137,761
ZIA · FY2010 · CA · contact PI
Clinical protocols for the treatment of GI cancer$34,440
ZIA · FY2010 · CA · contact PI